See product citations (2)
QUICK LINKS
CCT128930 is a potent, ATP-competitive and selective inhibitor of Akt2 (IC50: 6 nM). CCT128930 may act to exhibit marked antiproliferative activity against PTEN-deficient human tumor cell lines including U87MG human glioblastoma cells, LNCaP human prostate cancer cells and PC3 human prostate cancer cells (GI50′s: U87MG = 6.3 muM, LNCaP = 0.35 mumol/L and PC3 = 1.9 mumol/L). Furthermore, CCT128930 causes a G1 arrest in PTEN-null U87MG human glioblastoma cells and Akt pathway blockade.
Ordering Information
Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
CCT128930, 5 mg | sc-364459 | 5 mg | $153.00 | |||
CCT128930, 10 mg | sc-364459A | 10 mg | $286.00 |